← Back to Patent Explorer
US4028375A Expired / Lapsed US ⏱️ 0.0 years remaining

Thiadiazolylimidazolidinones

Assignee: Velsicol Chemical LLC
•
Filing: 1974-08-05
•
Granted: 1977-06-07
•
Expires: 1994-08-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention discloses compounds of the formula ##STR1## wherein R 1 is selected from the group consisting of alkyl, alkenyl, haloalkyl, alkoxy, alkylthio, alkylsulfonyl and alkylsulfinyl; and R 2 is selected from the group consisting of alkenyl, haloalkenyl and ##STR2## wherein R 3 and R 4 are selected from the group consisting of hydrogen and alkyl.

Inventors

  • 👤 John Krenzer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 08:11
CPC Classifications
C; C07; C07D; C07D285/00; C07D285/01; C07D285/02; C07D285/04; C07D285/12; C07D285/125; C07D285/135; C07D417/00; C07D417/02; C07D417/04

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 70 words
A compound of the formula ##STR11## wherein R' is selected from the group consisting of lower alkyl, lower alkenyl, lower haloalkyl, lower alkoxy, lower alkylthio, lower alkylsulfonyl and lower alkylsulfinyl; and R 2 is selected from the group consisting of lower alkenyl, lower chloroalkenyl, lower bromoalkenyl, and ##STR12## wherein R 3 and R 4 are selected from the group consisting of hydrogen and alkyl of up to three carbon atoms.
Claim 2
Dependent Claim 70 words
A compound of the formula ##STR11## wherein R' is selected from the group consisting of lower alkyl, lower alkenyl, lower haloalkyl, lower alkoxy, lower alkylthio, lower alkylsulfonyl and lower alkylsulfinyl; and R 2 is selected from the group consisting of lower alkenyl, lower chloroalkenyl, lower bromoalkenyl, and ##STR12## wherein R 3 and R 4 are selected from the group consisting of hydrogen and alkyl of up to three carbon atoms.
Claim 3
Dependent Claim 6 words
The compound of claim 1, 1-(5-t-butyl-1,3,4-thiadiazol-2-yl)-3-allyl-5-hydroxy-1,3-imidazolidin-2-one.
Claim 4
Dependent Claim 6 words
The compound of claim 1, 1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-3-allyl-5-hydroxy-1,3-imidazolidin-2-one.
Claim 5
Dependent Claim 6 words
The compound of claim 1, 1-(5-methyl-1,3,4-thiadiazol-2-yl)-3-propargyl-5-hydroxy-1,3-imidazolidin-2-one.
Claim 6
Dependent Claim 6 words
The compound of claim 1, 1-(5-methoxy-1,3,4-thiadiazol-2-yl)-3-but-3-enyl-5-hydroxy-1,3-imidazolidin-2-one.
Claim 7
Dependent Claim 6 words
The compound of claim 1, 1-(5-methylthio-1,3,4-thiadiazol-2-yl)-3-hex-4-enyl-5-hydroxy-1,3-imidazolidin-2-one.
Claim 8
Dependent Claim 6 words
The compound of claim 1, 1-(5-methylsulfonyl-1,3,4-thiadiazol-2-yl)-3-(1,1-dimethylprop-2-ynyl)-5-hydroxy-1,3-imidazolidin-2-one.
Claim 9
Dependent Claim 6 words
The compound of claim 1, 1-(5-methylsulfinyl-1,3,4-thiadiazol-2-yl)-3-(1,1-dipropylprop-2-ynyl)-5-hydroxy-1,3-imidazolidin-2-one.

References Cited (Backward Citations)

US3759939A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-06-06 1980-12-06 1981-06-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-06-06 1984-12-06 1985-06-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-06-06 1988-12-06 1989-06-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag